Feb. 24, 2022 First Clinical Trial of CRISPR-Based HIV Therapy Founded on Breakthrough Research at Lewis Katz School of Medicine By Katz CommunicationsThe first clinical trial of a gene-editing therapy for human immunodeficiency virus type 1 (HIV) […] Sep. 15, 2021 Groundbreaking Research at Temple Paves Way for First Trial of CRISPR-Based HIV Therapy in Human Patients By Katz Communications For the last seven years, researchers at the Lewis Katz School of Medicine at Temple University […] Aug. 28, 2021 Faculty Spotlight: Beata Kosmider, PhD By Katz CommunicationsBeata Kosmider, PhD, Associate Professor of Microbiology, Immunology, and Inflammation at the Lewis […] Aug. 13, 2021 Fels and Fox Chase Researchers Highlight Roles of TET2 and DNMT3A Mutations in Personalized Medicine-Guided Synthetic Lethality Against Leukemia By Katz CommunicationsIn a recent study published in Cancer Research, researchers from Fels Cancer Institute for […] May 24, 2021 Lewis Katz School of Medicine’s Center for Urban Bioethics Receives $1 Million Legacy Bequest and $50,000 Donation from Dr. Margaret Barnes By Katz CommunicationsBy the time Margaret M. Barnes arrived at Temple University’s medical school in 1977, she had […] Feb. 18, 2021 Excision BioTherapeutics Secures $60 Million to Advance CRISPR-Based Gene Editing Constructs Developed at Temple into Clinical Trial for People Living with Chronic HIV Infection By Katz Communications Excision BioTherapeutics, Inc. (Excision) has secured $60 million in investor financing to advance […] Dec. 10, 2020 New $2.5 Million NIDDK Grant Gives Temple Researchers Opportunity to Advance Tools to Predict Hospital Readmission Among Patients with Diabetes By Katz CommunicationsEach year in the United States, more than 1 million patients with diabetes make return trips to the […] Jul. 22, 2020 Temple Receives $5 Million Gift from Dr. Gerald M. Lemole and Emily Jane Lemole to Establish The Lemole Center for Integrated Lymphatics and Vascular Research By Katz CommunicationsGerald M. Lemole, MD, a 1962 graduate of the Lewis Katz School of Medicine at Temple University […] Jul. 2, 2019 HIV Eliminated from the Genomes of Living Animals By Katz Communications In a major collaborative effort, researchers at the Lewis Katz School of Medicine at Temple […]
Feb. 24, 2022 First Clinical Trial of CRISPR-Based HIV Therapy Founded on Breakthrough Research at Lewis Katz School of Medicine By Katz CommunicationsThe first clinical trial of a gene-editing therapy for human immunodeficiency virus type 1 (HIV) […] Sep. 15, 2021 Groundbreaking Research at Temple Paves Way for First Trial of CRISPR-Based HIV Therapy in Human Patients By Katz Communications For the last seven years, researchers at the Lewis Katz School of Medicine at Temple University […] Aug. 28, 2021 Faculty Spotlight: Beata Kosmider, PhD By Katz CommunicationsBeata Kosmider, PhD, Associate Professor of Microbiology, Immunology, and Inflammation at the Lewis […] Aug. 13, 2021 Fels and Fox Chase Researchers Highlight Roles of TET2 and DNMT3A Mutations in Personalized Medicine-Guided Synthetic Lethality Against Leukemia By Katz CommunicationsIn a recent study published in Cancer Research, researchers from Fels Cancer Institute for […] May 24, 2021 Lewis Katz School of Medicine’s Center for Urban Bioethics Receives $1 Million Legacy Bequest and $50,000 Donation from Dr. Margaret Barnes By Katz CommunicationsBy the time Margaret M. Barnes arrived at Temple University’s medical school in 1977, she had […] Feb. 18, 2021 Excision BioTherapeutics Secures $60 Million to Advance CRISPR-Based Gene Editing Constructs Developed at Temple into Clinical Trial for People Living with Chronic HIV Infection By Katz Communications Excision BioTherapeutics, Inc. (Excision) has secured $60 million in investor financing to advance […] Dec. 10, 2020 New $2.5 Million NIDDK Grant Gives Temple Researchers Opportunity to Advance Tools to Predict Hospital Readmission Among Patients with Diabetes By Katz CommunicationsEach year in the United States, more than 1 million patients with diabetes make return trips to the […] Jul. 22, 2020 Temple Receives $5 Million Gift from Dr. Gerald M. Lemole and Emily Jane Lemole to Establish The Lemole Center for Integrated Lymphatics and Vascular Research By Katz CommunicationsGerald M. Lemole, MD, a 1962 graduate of the Lewis Katz School of Medicine at Temple University […] Jul. 2, 2019 HIV Eliminated from the Genomes of Living Animals By Katz Communications In a major collaborative effort, researchers at the Lewis Katz School of Medicine at Temple […]
